Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1980-7-12
|
| pubmed:abstractText |
Total hemolytic complement (CH50) was measured in 174 synovial fluids (SF) to determine its diagnostic and and prognostic value. SF CH50 was reduced relative to serum CH50 in 61% of patients with rheumatoid arthritis and 60% of patients with crystal-induced arthritis. There was no correlation of SF CH50 levels with disease duration, SF leukocyte count, presence of IgM rheumatoid factor, or radiologic evidence of erosions.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0315-162X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
7
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
143-52
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:7373616-Arthritis, Reactive,
pubmed-meshheading:7373616-Arthritis, Rheumatoid,
pubmed-meshheading:7373616-Chondrocalcinosis,
pubmed-meshheading:7373616-Complement System Proteins,
pubmed-meshheading:7373616-Gout,
pubmed-meshheading:7373616-Humans,
pubmed-meshheading:7373616-Lupus Erythematosus, Systemic,
pubmed-meshheading:7373616-Synovial Fluid
|
| pubmed:articleTitle |
Clinical significance of synovial fluid total hemolytic complement activity.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|